The carboxy-terminus of merozoite surface protein 1: structure, specific antibodies and immunity to malaria
- PMID: 19627632
- DOI: 10.1017/S0031182009990515
The carboxy-terminus of merozoite surface protein 1: structure, specific antibodies and immunity to malaria
Abstract
Over the last 30 years, evidence has been gathered suggesting that merozoite surface protein 1 (MSP1) is a target of protective immunity against malaria. In a variety of experimental approaches using in vitro methodology, animal models and sero-epidemiological techniques, the importance of antibody against MSP1 has been established but we are still finding out what are the mechanisms involved. Now that clinical trials of MSP1 vaccines are underway and the early results have been disappointing, it is increasingly clear that we need to know more about the mechanisms of immunity, because a better understanding will highlight the limitations of our current assays and identify the improvements required. Understanding the structure of MSP1 will help us design and engineer better antigens that are more effective than the first generation of vaccine candidates. This review is focused on the carboxy-terminus of MSP1.
Similar articles
-
Immunity to recombinant plasmodium falciparum merozoite surface protein 1 (MSP1): protection in Aotus nancymai monkeys strongly correlates with anti-MSP1 antibody titer and in vitro parasite-inhibitory activity.Infect Immun. 2006 Aug;74(8):4573-80. doi: 10.1128/IAI.01679-05. Infect Immun. 2006. PMID: 16861644 Free PMC article.
-
Results from tandem Phase 1 studies evaluating the safety, reactogenicity and immunogenicity of the vaccine candidate antigen Plasmodium falciparum FVO merozoite surface protein-1 (MSP1(42)) administered intramuscularly with adjuvant system AS01.Malar J. 2013 Jan 23;12:29. doi: 10.1186/1475-2875-12-29. Malar J. 2013. PMID: 23342996 Free PMC article. Clinical Trial.
-
Biochemical and immunological characterization of bacterially expressed and refolded Plasmodium falciparum 42-kilodalton C-terminal merozoite surface protein 1.Infect Immun. 2003 Dec;71(12):6766-74. doi: 10.1128/IAI.71.12.6766-6774.2003. Infect Immun. 2003. PMID: 14638762 Free PMC article.
-
Antibodies and Plasmodium falciparum merozoites.Trends Parasitol. 2001 Apr;17(4):194-7. doi: 10.1016/s1471-4922(00)01946-2. Trends Parasitol. 2001. PMID: 11282510 Review.
-
Functional Antibodies and Protection against Blood-stage Malaria.Trends Parasitol. 2016 Nov;32(11):887-898. doi: 10.1016/j.pt.2016.07.003. Epub 2016 Aug 18. Trends Parasitol. 2016. PMID: 27546781 Review.
Cited by
-
A review of malaria vaccine clinical projects based on the WHO rainbow table.Malar J. 2012 Jan 9;11:11. doi: 10.1186/1475-2875-11-11. Malar J. 2012. PMID: 22230255 Free PMC article. Review.
-
Antibody Profile Comparison against MSP1 Antigens of Multiple Plasmodium Species in Human Serum Samples from Two Different Brazilian Populations Using a Multiplex Serological Assay.Pathogens. 2021 Sep 4;10(9):1138. doi: 10.3390/pathogens10091138. Pathogens. 2021. PMID: 34578170 Free PMC article.
-
Tailoring a Combination Preerythrocytic Malaria Vaccine.Infect Immun. 2015 Dec 14;84(3):622-34. doi: 10.1128/IAI.01063-15. Infect Immun. 2015. PMID: 26667840 Free PMC article.
-
Malaria Parasites: The Great Escape.Front Immunol. 2016 Nov 7;7:463. doi: 10.3389/fimmu.2016.00463. eCollection 2016. Front Immunol. 2016. PMID: 27872623 Free PMC article. Review.
-
Quantitative analysis of immune response and erythropoiesis during rodent malarial infection.PLoS Comput Biol. 2010 Sep 30;6(9):e1000946. doi: 10.1371/journal.pcbi.1000946. PLoS Comput Biol. 2010. PMID: 20941388 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials